Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial.
Yara L Verschoor
,
Joris van de Haar
,
José G van den Berg
,
Johanna W van Sandick
,
Liudmila L Kodach
,
Jolanda M van Dieren
,
Sara Balduzzi
,
Cecile Grootscholten
,
Marieke E IJsselsteijn
,
Alexander A F A Veenhof
,
Koen J Hartemink
,
Marieke A Vollebergh
,
Adham Jurdi
,
Shruti Sharma
,
Erik Spickard
,
Emilia C Owers
,
Annemarieke Bartels-Rutten
,
Peggy den Hartog
,
Noel F C C de Miranda
,
Monique E van Leerdam
,
John B A G Haanen
,
Ton N Schumacher
,
Emile E Voest
,
Myriam Chalabi
More about this publication
Nature medicine
Volume
30
Issue nr.
5
Pages
1499
Publication date
01-05-2024
Full text links
Publisher website (DOI)
10.1038/s41591-024-02898-8
Europe PubMed Central
38448792
Pubmed
38448792